Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: A case report

RATIONALE: Tumor-induced osteomalacia (TIO) is curable by tumor resection, but detection of the tumor can be challenging. Overproduction of fibroblast growth factor 23 (FGF23) by the tumor causes hypophosphatemia and consequently induces inappropriate bone turnover. Conventionally oral phosphate sup...

Descripción completa

Detalles Bibliográficos
Autores principales: Oe, Yuki, Kameda, Hiraku, Nomoto, Hiroshi, Sakamoto, Keita, Soyama, Takeshi, Cho, Kyu Yong, Nakamura, Akinobu, Iwasaki, Koji, Abo, Daisuke, Kudo, Kohsuke, Miyoshi, Hideaki, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601343/
https://www.ncbi.nlm.nih.gov/pubmed/34797338
http://dx.doi.org/10.1097/MD.0000000000027895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601343/
https://www.ncbi.nlm.nih.gov/pubmed/34797338
http://dx.doi.org/10.1097/MD.0000000000027895

Ejemplares similares